Thursday, November 19, 2026

Real-time quaking-induced conversion detection of pathological prion protein in skeletal muscle, nasal and neural tissues of cattle with natural L-BSE

 ORIGINAL RESEARCH 


article Front. Neurosci., 10 November 2026 Sec. Neurodegeneration Volume 20 - 2026 | https://doi.org/10.3389/fnins.2026.1999556

Real-time quaking-induced conversion detection of pathological prion protein in skeletal muscle, nasal and neural tissues of cattle with natural L-BSE

Christina Doriana Orrù Christina Doriana Orrù 1 E Elena Bozzetta 2 Barbara Moroni Barbara Moroni 2* Alessandra Favole Alessandra Favole 2 L Luana Dell’Atti 2 C Cristiano Corona 2 B Barbara Iulini 2 P Pier Luigi Acutis 2 C Cristina Casalone 2 Maria Mazza Maria Mazza 2

1. Rocky Mountain Laboratories (RML), National Institutes of Health (NIH), Hamilton, MT, United States 2. Italian Reference Laboratory for TSEs, Istituto Zooprofilattico Serimentale del Piemonte, Turin, Italy

Abstract Introduction: Bovine spongiform encephalopathy (BSE) includes classical BSE (C-BSE) and two atypical forms, high-type (H-BSE) and low-type (L-BSE). Compared with C-BSE, the peripheral distribution and tissue tropism of atypical BSE remain poorly characterized. The apparent spontaneous occurrence of atypical BSE and its potential food safety implications highlight the need for highly sensitive surveillance methods. This study aimed to develop and standardize real-time quaking-induced conversion (RT-QuIC) protocols to investigate PrPSc-associated seeding activity in skeletal muscle, nasal, and neural tissues of cattle naturally affected by L-BSE.Methods: Brain, spinal cord, skeletal muscle, and olfactory tissues were collected from naturally affected Italian cattle and analyzed using RT-QuIC to detect PrPSc-associated seeding activity.Results: Seeding activity was detected in skeletal muscle and olfactory tissues, as well as in the brain and spinal cord, suggesting the involvement of neuromuscular and olfactory tissues in L-BSE.Discussion: Consistent with previous experimental observations, the detection of seeding activity in skeletal muscle raises the possibility that this tissue may contribute to L-BSE-associated infectivity, although RT-QuIC results alone cannot establish tissue infectivity. These findings highlight the importance of highly sensitive BSE surveillance in cattle intended for slaughter to facilitate the early detection of atypical BSE cases and minimize potential food safety risks.

snip…

4 Discussion In this study, we detected pathological prion protein-associated seeding activity by real-time quaking-induced conversion (RT-QuIC) in skeletal muscle, nasal, and neuronal tissues from cattle naturally affected by L-type BSE. Positive reactions were obtained in several anatomically distinct skeletal muscles, including the longissimus dorsi, trapezius, thigh, and intercostal muscles, and were accompanied by the detection of seeding activity in the spinal cord, olfactory mucosa, and choana. These findings provide further evidence that the distribution of prion-associated seeding activity in naturally occurring L-type BSE extends beyond the central nervous system and may involve multiple peripheral tissues.

The detection of prion-associated seeding activity in skeletal muscles is consistent with previous observations in atypical BSE. PrPSc deposition and, in some instances, infectivity have previously been demonstrated in skeletal muscle from cattle affected by both L-type and H-type BSE. In particular, infectivity has been demonstrated in several skeletal muscles from cattle affected by atypical BSE, including naturally occurring BASE cases (Lombardi et al., 2008; Iwamaru et al., 2010; Costassa et al., 2016). Evidence of prion-associated material or infectivity in skeletal muscle has also been reported in other prion diseases, including classical and atypical scrapie/Nor98 in sheep (Andréoletti et al., 2011), chronic wasting disease in cervids (Angers et al., 2006; Vuong et al., 2025), and experimental scrapie models in rodents (Patrick et al., 2002). Collectively, these observations indicate that skeletal muscle can harbor prion-associated material across different prion diseases, although its distribution and abundance may vary substantially among tissues and disease models.

This variability is also evident in studies of atypical BSE. A previous RT-QuIC investigation of tissues from cattle affected by atypical BSE detected seeding activity in only one of the skeletal muscles examined, whereas other studies reported either low levels of infectivity or limited PrPSc accumulation in skeletal muscles (Suardi et al., 2012; Sawada et al., 2019; Balkema-Buschmann et al., 2019). Our findings therefore extend the existing evidence by demonstrating RT-QuIC-detectable seeding activity in several anatomically distinct skeletal muscles from naturally affected cattle. The detection of seeding activity in the longissimus dorsi, trapezius, thigh, and intercostal muscles is particularly relevant because these tissues are not conventionally regarded as major sites of prion accumulation in BSE. Previous investigations have suggested that skeletal muscle involvement in atypical BSE may be associated, at least in part, with the presence of PrPSc within or around muscle spindles and with involvement of peripheral nerves (Balkema-Buschmann et al., 2019).

The presence of seeding activity in multiple skeletal muscles may also be consistent with the proposed neuroanatomical routes of peripheral dissemination of L-type BSE prions. L-type BSE has been shown to involve the peripheral nervous system, with PrPSc accumulation reported in peripheral nerves and ganglia and evidence suggesting centrifugal spread from the central nervous system along neuronal pathways (Balkema-Buschmann et al., 2019; Iwamaru et al., 2010). Although the present study does not allow us to establish the mechanism underlying the presence of prion-associated material in skeletal muscle, the simultaneous detection of seeding activity in neural and muscular tissues is compatible with a possible association between peripheral neural pathways and prion deposition in muscle. Whether the observed distribution reflects specific tissue tropism, peripheral dissemination, local accumulation, or the contribution of neural structures associated with the sampled tissues remains to be established.

The detection of seeding activity in the olfactory mucosa is also noteworthy. L-type BSE is characterized by prominent involvement of the rhinencephalon and other regions of the nervous system, and previous studies have demonstrated a broader neuroanatomical distribution of PrPSc in L-type BSE than in classical BSE. The RT-QuIC detection of prion seeding activity in the olfactory mucosa may therefore reflect involvement of tissues associated with the olfactory nervous system. However, further studies are required to determine whether this finding represents a specific feature of L-type BSE pathogenesis or is indicative of a broader peripheral distribution of prion-associated material.

Importantly, RT-QuIC-detectable seeding activity should not be interpreted as direct evidence of infectivity. RT-QuIC detects the capacity of prion-associated material to seed the conversion of recombinant prion protein, whereas the demonstration of infectivity requires biological transmission studies. Accordingly, the present findings establish the presence of RT-QuIC-detectable prion seeding activity in the examined tissues but do not demonstrate that the detected material is infectious. This distinction is particularly important when considering the potential biological and food-safety implications of prion-associated material in skeletal muscle. Nevertheless, previous studies demonstrated infectivity in skeletal muscles from cattle affected by L-type BSE, despite minimal PrPSc accumulation detectable by conventional diagnostic methods, providing relevant biological context for the present findings (Lombardi et al., 2008; Iwamaru et al., 2010). Thus, although seeding activity cannot be directly equated with infectivity, its detection may indicate the presence of biologically relevant prion-associated material.

In contrast to classical BSE, in which pathological prion protein accumulation is predominantly confined to the central nervous system (Buschmann et al., 2005), the peripheral distribution of atypical BSE agents remains poorly understood. Previous studies have reported limited or undetectable PrPSc accumulation in peripheral organs of both naturally and experimentally infected cattle, consistent with the relatively restricted tissue distribution and lower PrPSc burden characteristic of atypical BSE (Suardi et al., 2012; Okada et al., 2011; Konold et al., 2012; Balkema-Buschmann et al., 2019). The present findings therefore provide additional evidence that low levels of prion-associated material may be present in peripheral tissues despite the generally limited peripheral distribution observed in atypical BSE.

An important aspect of the present study is the comparison of conventional diagnostic approaches. RT-QuIC detected seeding activity in skeletal muscle and other peripheral tissues from naturally affected cattle, including tissues in which prion-associated material may be present at levels below the analytical sensitivity of conventional methods. This is particularly relevant for one of the three Italian L-type BSE cases examined in the present study, which had previously been investigated by Suardi et al. (2012). In that study, peripheral tissues, including skeletal muscles, were examined using the official confirmatory methods established under Regulation (EC) No. 999/2001. PrPSc deposition was detected by immunohistochemistry (IHC) in selected peripheral tissues, whereas Western blot (WB) analysis was negative, illustrating the difficulty of detecting very low levels of pathological prion protein using conventional biochemical methods. The availability of complementary data from the same animal therefore provides an opportunity to further characterize the distribution of prion-associated material using a highly sensitive amplification-based assay.

The detection of RT-QuIC seeding activity in skeletal muscles from the naturally affected Italian cases provides additional evidence that peripheral tissues can contain low levels of prion-associated material that may be difficult to detect using conventional diagnostic approaches. Moreover, seeding activity was detected in several anatomically distinct skeletal muscles, suggesting that skeletal muscle involvement may not be restricted to a single anatomical site or individual case. At the same time, the present study does not establish whether differences in seeding activity among tissues reflect differences in prion tropism, peripheral dissemination, local accumulation, or the contribution of associated neural structures.

The detection of prion-associated seeding activity in skeletal muscle may also be relevant from a food-safety perspective, given the implications of BSE for food safety and public health (Kumagai et al., 2019). Atypical BSE, including BASE, has demonstrated distinct biological properties compared with classical BSE, including a broader host range and efficient transmissibility in several mammalian models, including non-human primates (Béringue et al., 2007; Béringue et al., 2008; Comoy et al., 2008). Experimental transmission studies in primates have further suggested that BASE may exhibit pathogenic properties distinct from those of C-BSE and have raised the possibility of a biological relationship with a rare subgroup of apparently sporadic CJD cases (Comoy et al., 2008). Although the detection of RT-QuIC seeding activity in skeletal muscle does not establish an associated risk of transmission, the presence of prion-associated material in tissues potentially entering the food chain warrants consideration in future risk assessments, particularly in light of previous evidence of infectivity in skeletal muscle from L-type BSE cases.

From a surveillance perspective, these findings are also relevant because atypical BSE is generally considered a spontaneous disease of aged cattle, making its complete eradication unlikely (European Food Safety Authority et al., 2025). Continued active and passive surveillance therefore remains important for the identification of affected animals and for preventing potentially contaminated tissues from entering the food and feed chains. In this context, the development and implementation of highly sensitive diagnostic approaches capable of detecting low levels of prion-associated material within timeframes compatible with food-chain surveillance may contribute to improved risk management and consumer protection.

Taking together, our findings extend the existing evidence on the peripheral distribution of prion-associated material in L-type BSE and demonstrate that RT-QuIC-detectable seeding activity can be identified in multiple skeletal muscles from naturally affected cattle. The detection of seeding activity in several anatomically distinct muscles, together with its presence in the spinal cord, olfactory mucosa, and choana, supports a broader tissue distribution of prion-associated material than that suggested by conventional diagnostic approaches alone. Further studies involving larger numbers of naturally affected animals, quantitative assessment of seeding activity, investigation of its anatomical distribution, and, where feasible, correlation with infectivity bioassays will be necessary to determine the consistency and biological significance of prion seeding activity in skeletal muscle and other peripheral tissues.

https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2026.1999556/full

6.8.​ Bovine spongiform encephalopathy (Chapter 11.4.), Application for official recognition by the OIE of risk status for bovine spongiform encephalopathy (Chapter 1.8.) and Glossary definition for ‘protein meal’

Background

In February 2018, following preliminary work and scientific exchanges, the Code Commission and the Scientific Commission agreed to an in-depth review of Chapter 11.4. Bovine spongiform encephalopathy (BSE). The OIE convened three different ad hoc Groups between July 2018 and March 2019: i) an ad hoc Group on BSE risk assessment, which met twice, ii) an ad hoc Group on BSE surveillance, which met once, and iii) a joint ad hoc Group on BSE risk assessment and surveillance, which met once. The Code Commission, at its September 2019 meeting, reviewed the four ad hoc Group reports and the opinion of the Scientific Commission regarding the draft revised chapter and circulated a revised draft Chapter 11.4. for comments.

In February 2020, the Code Commission considered comments received on the revised draft Chapter 11.4. and requested that the joint ad hoc Group on BSE risk assessment and surveillance be reconvened to address comments of a technical nature. In June 2020, the joint ad hoc Group was convened to address relevant comments and was also requested to review Chapter 1.8. Application for official recognition by the OIE of risk status for bovine spongiform encephalopathy to ensure alignment with the proposed changes in Chapter 11.4.

In September 2020, the Code Commission reviewed the joint ad hoc Group report and the revised draft Chapters 11.4. and 1.8. and made some additional amendments and circulated the revised chapters for comments in its September 2020 report. In February 2021, the Commission considered comments received and amended the chapters, as appropriate, and circulated the revised chapters for a third round of comments.

In preparation for the September 2021 meetings, some members of the Code Commission and the Scientific Commission met to discuss key aspects of the revision of Chapters 11.4. and 1.8. to ensure a common understanding of the main concerns raised by Members, the decisions made on the revised chapters and their impact on the official status recognition, as well as on the adapted procedures that will be required. During this meeting, it was agreed that each Commission would address the issues relevant to its meeting and document discussions in their respective reports.

Discussion

Snip…see;

https://www.aphis.usda.gov/sites/default/files/Sep-2021-Full-Comm-Report.docx

***> atypical Bovine Spongiform Encephalopathy BSE TSE Prion <***

Transmission of atypical BSE: a possible origin of Classical BSE in cattle

***> Results: After 6 years of incubation, 3/4 animals (2/2 steers IC challenged with brain from P1 L-BSE oral challenge and 1/2 steer IC challenged with brain from P1 H-BSE oral challenge) developed clinical disease. Analysis of these animals revealed high levels of PrPSc in their brains, having biochemical properties similar to that of PrPSc in C-BSE.

https://prion2023.org/wp-content/uploads/2023/10/Meeting-book-final-version2.pdf

https://web.archive.org/web/20250828201533/https://prion2023.org/wp-content/uploads/2023/10/Meeting-book-final-version2.pdf

https://www.researchgate.net/profile/Syed-Zahid-Shah/publication/378314391_Meeting-book-final-version_prion_2023/links/65d44dad28b7720cecdca95f/Meeting-book-final-version-prion-2023.pdf

***> Conclusion: These results demonstrate the oral transmission potential of atypical BSE in cattle. Surprisingly, regardless of which atypical type of BSE was used for P1 oral challenge, PrPSc in the P2 animals acquired biochemical characteristics similar to that of PrPSc in C-BSE, suggesting atypical BSE as a possible origin of C-BSE in UK.

https://prion2023.org/wp-content/uploads/2023/10/Meeting-book-final-version2.pdf

https://web.archive.org/web/20250828201533/https://prion2023.org/wp-content/uploads/2023/10/Meeting-book-final-version2.pdf

https://www.researchgate.net/profile/Syed-Zahid-Shah/publication/378314391_Meeting-book-final-version_prion_2023/links/65d44dad28b7720cecdca95f/Meeting-book-final-version-prion-2023.pdf

***> Atypical BSE TSE Prion in cattle <***

Atypical BSE in cattle

THE recent diagnosis of two atypical bovine spongiform encephalopathy (BSE) cases in Great Britain (March 2023 in Cornwall and December 2024 in Dumfries and Galloway) and one in the Republic of Ireland (in November 2023) warrants a reminder about this notifiable disease.

Since 2005, a total of 17 cases have been detected in Great Britain.1 Unlike classical BSE, which resulted in over 180,000 cases in Great Britain and was predominantly associated with the consumption of feed contaminated with the BSE agent, and where the last case was confirmed in Ayrshire in May 2024, atypical BSE is believed to be a spontaneous disease in cattle found in approximately one in 1,000,000 tested cattle based on French data,2 similar to the sporadic Creutzfeldt- Jakob disease in people. There is currently no evidence that atypical BSE causes a disease in people, although it can be transmitted experimentally to other species by intracerebral inoculation, including primates.3–5 The World Organisation for Animal Health does not include atypical BSE in its geographical BSE risk status assessment.

Despite differences in terms of epidemiological, molecular and biological phenotype compared with classical BSE, atypical BSE is currently treated as if it were classical BSE in accordance with EU and UK legislation: once a case is identified, all cohort animals born and reared with the affected animal during the first 12 months of its life, and all offspring born within 24 months of its clinical onset, are culled and tested for BSE, which does seem to be at odds with the hypothesis that it is a spontaneous disease. This is more a precautionary measure to maintain confidence in the beef trade and protect consumers while more knowledge about this disease is obtained.

Almost all current knowledge on atypical BSE is based on experimental infection because this spontaneous

VET RECORD | 29 March–12 April 2025

disease has generally only been found in aged downer cows, which is difficult to replicate experimentally in the host species. Intracerebral inoculation of brain tissue from an affected cow causes disease in cattle in less than two years, unlike the natural disease that usually occurs in animals over eight years of age.

The vast majority of cases have been identified by active monitoring of fallen stock or emergency slaughter of cattle, where only the brain sample of various stages of autolysis is generally available. Little is known of where the atypical BSE agent can be found in natural disease, other than in the brain, because all the cases confirmed have been identified after death through active surveillance, by which time most peripheral tissue has been disposed of. Limited material from a single case of a naturally affected cow was tested in Italy by mouse bioassay, which found infectivity in muscle.6 In experimental disease generated by intracerebral inoculation of cattle, infectivity can be detected in the brain and spinal cord, ganglia, peripheral nerves and skeletal muscles, similar to classical BSE, but not in peripheral lymphoid tissue.6–8

Early reporting of clinical suspects is needed so that the live animal or the whole carcase can be delivered to an APHA regional laboratory for tissue sampling. This is made more difficult due to the subtlety of clinical signs based on experimental disease. Clinical cases may not be as over- reactive or nervous as classical BSE cases; some may, in fact, be dull, but what most cases have in common is that they have difficulty getting up and eventually end up as downer cows, and only the clinical history may reveal some prior behavioural or locomotor changes. High creatinine kinase serum levels and nibbling in response to scratching the tail head or back were some features in experimental disease,8, 9 but it is not known whether this is also seen in natural disease.

In general, BSE should be considered as a differential diagnosis in all downer cows that do not respond to treatment, where the blood results do not support the presence of a metabolic disease and where the cause cannot be determined with confidence.

Since BSE is a notifiable disease, suspected cases of BSE in Great Britain must be reported to the local APHA office.

Changes are imminent in the reporting of fallen stock cattle, which will require the owner to state whether the animal displayed signs of changes in behaviour, sensation or locomotion before death, in addition to the likely cause of death or disease. This is to obtain a better profile of the clinical history, if cattle are retrospectively diagnosed as BSE cases, which has happened in all BSE cases confirmed since 2010: none has been reported as a clinical suspect.

“BSE should be considered as a differential diagnosis in all downer cows that do not respond to treatment”

Timm Konold, TSE lead scientist

Brenda Rajanayagam, workgroup leader for the data systems group

APHA Weybridge, New Haw, Addlestone, Surrey KT15 3NB email: timm.konold@apha.gov.uk

Keith Meldrum, former chief veterinary officer The Orchard, Swaynes Lane, Guildford, Surrey GU1 2XX

References

1 APHA. Cattle: TSE surveillance statistics. Overview of Great Britain statistics. 2025. https://bit.ly/4ho5Nds (accessed 19 March 2025)

Atypical BSE In Cattle

https://bvajournals.onlinelibrary.wiley.com/doi/10.1002/vetr.5400

https://bvajournals.onlinelibrary.wiley.com/doi/epdf/10.1002/vetr.5400

“According to the World Organisation for Animal Health (WOAH), Terrestrial Manual 2021, atypical BSE, caused by H- and L-type BSE agents, is rare and is believed to occur spontaneously in all bovine populations at a very low rate and has only been identified in older cattle.”

***Moreover, sporadic disease has never been observed in breeding colonies or primate research laboratories, most notably among hundreds of animals over several decades of study at the National Institutes of Health25, and in nearly twenty older animals continuously housed in our own facility.***

Even if the prevailing view is that sporadic CJD is due to the spontaneous formation of CJD prions, it remains possible that its apparent sporadic nature may, at least in part, result from our limited capacity to identify an environmental origin.

https://www.nature.com/articles/srep11573

https://www.ars.usda.gov/research/publications/publication/?seqNo115=361032

Real-time quaking-induced conversion detection of pathological prion protein in skeletal muscle, nasal and neural tissues of cattle with natural L-BSE

10 November 2026

The detection of prion-associated seeding activity in skeletal muscle may also be relevant from a food-safety perspective, given the implications of BSE for food safety and public health (Kumagai et al., 2019). Atypical BSE, including BASE, has demonstrated distinct biological properties compared with classical BSE, including a broader host range and efficient transmissibility in several mammalian models, including non-human primates (Béringue et al., 2007; Béringue et al., 2008; Comoy et al., 2008). Experimental transmission studies in primates have further suggested that BASE may exhibit pathogenic properties distinct from those of C-BSE and have raised the possibility of a biological relationship with a rare subgroup of apparently sporadic CJD cases (Comoy et al., 2008). Although the detection of RT-QuIC seeding activity in skeletal muscle does not establish an associated risk of transmission, the presence of prion-associated material in tissues potentially entering the food chain warrants consideration in future risk assessments, particularly in light of previous evidence of infectivity in skeletal muscle from L-type BSE cases.

https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2026.1999556/full

The Mad Cow That Stole Christmas, 20 Years Later, What Has Changed, Nothing

THE USA has systematically covered up mad cow disease, in my honest opinion, the USA mad cow disease today, is Chronic Wasting Disease CWD TSE Prion disease in Cervid, they can't cover that up.

https://animalhealthreportpriontse.blogspot.com/2023/12/the-mad-cow-that-stole-christmas-23.html

2026 USDA EXPLANATORY NOTES ANIMAL AND PLANT HEALTH INSPECTION SERVICE CWD, Scrapie, BSE, and CJD, Singeltary Review

https://transmissiblespongiformencephalopathy.blogspot.com/2026/11/2026-usda-explanatory-notes-animal-and.html

https://prpsc.proboards.com/thread/268/2026-explanatory-notes-aphis-review

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home